Histone deacetylase activity mediates acquired resistance towards structurally diverse HSP90 inhibitors
出版年份 2017 全文链接
标题
Histone deacetylase activity mediates acquired resistance towards structurally diverse HSP90 inhibitors
作者
关键词
-
出版物
Molecular Oncology
Volume 11, Issue 5, Pages 567-583
出版商
Wiley
发表日期
2017-03-17
DOI
10.1002/1878-0261.12054
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase II data for entinostat, a class 1 selective histone deacetylase inhibitor, in patients whose breast cancer is progressing on aromatase inhibitor therapy.
- (2017) A. M. Wardley et al. JOURNAL OF CLINICAL ONCOLOGY
- Development of Heat Shock Protein (Hsp90) Inhibitors To Combat Resistance to Tyrosine Kinase Inhibitors through Hsp90–Kinase Interactions
- (2016) Meining Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1)
- (2015) S. Ramalingam et al. ANNALS OF ONCOLOGY
- P-glycoprotein confers acquired resistance to 17-DMAG in lung cancers with an ALK rearrangement
- (2015) Hee Joung Kim et al. BMC CANCER
- Phase I study of KW-2478, a novel Hsp90 inhibitor, in patients with B-cell malignancies
- (2015) K Yong et al. BRITISH JOURNAL OF CANCER
- Phase I/II Study of HSP90 Inhibitor AUY922 and Erlotinib forEGFR-Mutant Lung Cancer With Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
- (2015) Melissa L. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Maximizing the Therapeutic Potential of HSP90 Inhibitors
- (2015) L. M. Butler et al. MOLECULAR CANCER RESEARCH
- Histone Deacetylases Positively Regulate Transcription through the Elongation Machinery
- (2015) Celeste B. Greer et al. Cell Reports
- Targeting HSF1 sensitizes cancer cells to HSP90 inhibition
- (2015) Yaoyu Chen et al. Oncotarget
- Ganetespib, a Novel Hsp90 Inhibitor in Patients With KRAS Mutated and Wild Type, Refractory Metastatic Colorectal Cancer
- (2014) Andrea Cercek et al. Clinical Colorectal Cancer
- Drugging the HDAC6–HSP90 interplay in malignant cells
- (2014) Oliver H. Krämer et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- TAp73 Protein Stability Is Controlled by Histone Deacetylase 1 via Regulation of Hsp90 Chaperone Function
- (2013) Jin Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumors
- (2012) M. A. Dickson et al. ANNALS OF ONCOLOGY
- Inhibiting HSP90 to Treat Cancer: A Strategy in Evolution
- (2012) L. Whitesell et al. CURRENT MOLECULAR MEDICINE
- Modulation of Histone Deacetylase 6 (HDAC6) Nuclear Import and Tubulin Deacetylase Activity through Acetylation
- (2012) Yuanjing Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers
- (2011) Komal Jhaveri et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Physical and Functional HAT/HDAC Interplay Regulates Protein Acetylation Balance
- (2010) Alessia Peserico et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Acquired Resistance to 17-Allylamino-17-Demethoxygeldanamycin (17-AAG, Tanespimycin) in Glioblastoma Cells
- (2009) N. Gaspar et al. CANCER RESEARCH
- MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?
- (2009) Ann F. Chambers CANCER RESEARCH
- HDAC6 inhibition enhances 17-AAG-mediated abrogation of hsp90 chaperone function in human leukemia cells
- (2008) R. Rao et al. BLOOD
- P-Glycoprotein-Mediated Resistance to Hsp90-Directed Therapy Is Eclipsed by the Heat Shock Response
- (2008) A. K. McCollum et al. CANCER RESEARCH
- Silencing of HSP90 Cochaperone AHA1 Expression Decreases Client Protein Activation and Increases Cellular Sensitivity to the HSP90 Inhibitor 17-Allylamino-17-Demethoxygeldanamycin
- (2008) J. L. Holmes et al. CANCER RESEARCH
- Role of Acetylation and Extracellular Location of Heat Shock Protein 90 in Tumor Cell Invasion
- (2008) Y. Yang et al. CANCER RESEARCH
- NVP-AUY922: A Novel Heat Shock Protein 90 Inhibitor Active against Xenograft Tumor Growth, Angiogenesis, and Metastasis
- (2008) S. A. Eccles et al. CANCER RESEARCH
- Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma
- (2008) D. B. Solit et al. CLINICAL CANCER RESEARCH
- A Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Hormone-Refractory Metastatic Prostate Cancer
- (2008) E. I. Heath et al. CLINICAL CANCER RESEARCH
- 4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer
- (2007) Paul A. Brough et al. JOURNAL OF MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now